Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Front Immunol ; 12: 662894, 2021.
Article in English | MEDLINE | ID: mdl-33968064

ABSTRACT

Background: The early initiation of antiretroviral therapy (ART) in HIV-1-infected infants reduces mortality and prevents early CD4 T-cell loss. However, the impact of early ART on the immune system has not been thoroughly investigated in children over five years of age or adolescents. Here, we describe the levels of naive CD4 and CD8 T lymphocytes (CD4/CD8TN), reflecting the quality of immune reconstitution, as a function of the timing of ART initiation (early (<6 months) versus late (≥24 months of age)). Methods: The ANRS-EP59-CLEAC study enrolled 27 children (5-12 years of age) and nine adolescents (13-17 years of age) in the early-treatment group, and 19 children (L-Ch) and 21 adolescents (L-Ado) in the late-treatment group. T lymphocytes were analyzed by flow cytometry and plasma markers were analyzed by ELISA. Linear regression analysis was performed with univariate and multivariate models. Results: At the time of evaluation, all patients were on ART and had a good immunovirological status: 83% had HIV RNA loads below 50 copies/mL and the median CD4 T-cell count was 856 cells/µL (interquartile range: 685-1236 cells/µL). In children, early ART was associated with higher CD8TN percentages (medians: 48.7% vs. 31.0%, P = 0.001), and a marginally higher CD4TN (61.2% vs. 53.1%, P = 0.33). In adolescents, early ART was associated with low CD4TN percentages and less differentiated memory CD8 T cells. CD4TN and CD8TN levels were inversely related to cellular activation and gut permeability. Conclusion: In children and adolescents, the benefits of early ART for CD8TN were clear after long-term ART. The impact of early ART on CD4TN appears to be modest, because pediatric patients treated late respond to HIV-driven CD4 T-lymphocyte loss by the de novo production of TN cells in the thymus. Our data also suggest that current immune activation and/or gut permeability has a negative impact on TN levels. Clinical Trial Registration: ClinicalTrials.gov, identifier NCT02674867.


Subject(s)
Antiretroviral Therapy, Highly Active , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/immunology , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/virology , HIV-1/drug effects , Adolescent , CD4-Positive T-Lymphocytes/metabolism , Child , Child, Preschool , Female , Humans , Lymphocyte Activation , Lymphocyte Count , Male , Time-to-Treatment
2.
J Virol ; 86(19): 10540-6, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22811522

ABSTRACT

It has been hypothesized that neutralizing antibodies (NAbs) should have broad specificity to be effective in protection against diverse HIV-1 variants. The mother-to-child transmission model of HIV-1 provides the opportunity to examine whether the breadth of maternal NAbs is associated with protection of infants from infection. Samples were obtained at delivery from 57 transmitting mothers (T) matched with 57 nontransmitting mothers (NT) enrolled in the multicenter French perinatal cohort (ANRS EPF CO1) between 1990 and 1996. Sixty-eight (59.6%) and 46 (40.4%) women were infected by B and non-B viruses, respectively. Neutralization assays were carried out with TZM-bl cells, using a panel of 10 primary isolates of 6 clades (A, B, C, F, CRF01_AE, and CRF02_AG), selected for their moderate or low sensitivity to neutralization. Neutralization breadths were not statistically different between T and NT mothers. However, a few statistically significant differences were observed, with higher frequencies or titers of NAbs toward several individual strains for NT mothers when the clade B-infected or non-clade B-infected mothers were analyzed separately. Our study confirms that the breadth of maternal NAbs is not associated with protection of infants from infection.


Subject(s)
Antibodies, Neutralizing/chemistry , HIV Infections/transmission , HIV-1/metabolism , Neutralization Tests/methods , Pregnancy Complications, Infectious/diagnosis , Adult , Case-Control Studies , Cohort Studies , Female , HIV Antibodies/immunology , HIV Infections/immunology , Humans , Infant, Newborn , Infectious Disease Transmission, Vertical , Male , Maternal Exposure , Mothers , Pregnancy , Pregnancy Complications, Infectious/immunology
3.
C R Biol ; 332(7): 603-12, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19523600

ABSTRACT

Psychometric tests obtained from 6564 young men were studied as a function of the parents' ages at conception and of some characteristics of the subject's postnatal environment. Individual scores, from 0 to 20, were divided into two groups: n(1)11 and n(2)<11. In univariate analysis, scores <11 were respectively related to low height, high number of siblings and junior in birth order, subject's and parents' tobacco consumption, parents' alcohol consumption, subject's and parents' low academic standard, parents' youth or ageing at conception. In multivariate analysis, these scores remained related to low height, junior in birth order, subject's and parents' tobacco consumption, parents' low academic standard, parents' youth (both <20). Regarding the respective influences of the environment and of the subject's genome on his cerebral development, one can hypothesize a complementarity between these two factors through the possibility of a genetically determined individual synaptic potential, revealing itself, more or less, according to environmental conditions.


Subject(s)
Aging/physiology , Aptitude/physiology , Environment , Parents , Adolescent , Adult , Aged , Alcohol Drinking/psychology , Analysis of Variance , Body Height , Education , Fathers , Female , Humans , Intelligence Tests , Male , Middle Aged , Mothers , Psychometrics , Reading , Smoking/psychology , Socioeconomic Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...